Adalimumab (anti-TNF-α)

Tax included
Adalimumab (anti-TNF-α) is a human monoclonal IgG1 antibody targeting tumour necrosis factor α (TNF-α).
MedChemExpress 
HY-P9908A

Data sheet

Size
Multiple sizes
Reactivity
TNF Receptor
Application
COVID-19-immunoregulation
CAS
331731-18-1